Literature DB >> 34234293

Management of amblyopia in pediatric patients: Current insights.

Sagnik Sen1, Pallavi Singh1, Rohit Saxena2.   

Abstract

Amblyopia is a cause of significant ocular morbidity in pediatric population and may lead to visual impairment in future life. It is caused due to formed visual deprivation or abnormal binocular interactions. Several risk factors in pediatric age group may lead to this disease. Author groups have tried managing different types of amblyopia, like anisometropic amblyopia, strabismic amblyopia and combined mechanism amblyopia, with optical correction, occlusion therapy, penalization, binocular therapy and surgery. We review historical and current management strategies of different types of amblyopia affecting children and outcomes in terms of visual acuity, binocularity and ocular deviation, highlighting evidence from recent studies. Literature searches were performed through Pubmed. Risk factors for amblyopia need to be identified in pediatric population as early in life as possible and managed accordingly, as visual outcomes in amblyopia are best if treated at the earliest. Although, monocular therapies like occlusion or penalization have been shown to be quite beneficial over the years, newer concepts related to binocular vision therapy are still evolving.
© 2021. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.

Entities:  

Mesh:

Year:  2021        PMID: 34234293      PMCID: PMC8727565          DOI: 10.1038/s41433-021-01669-w

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  156 in total

1.  Evaluation of Occlusion Treatment Outcomes for Unilateral Amblyopia Using Different Definitions of Outcome.

Authors:  Liping Su; Hong Yan; Yongxin Xing; Yuhai Zhang; Baoyi Zhu
Journal:  Semin Ophthalmol       Date:  2014-11-04       Impact factor: 1.975

2.  Perceptual learning.

Authors:  E J GIBSON
Journal:  Annu Rev Psychol       Date:  1963       Impact factor: 24.137

Review 3.  Stereopsis and amblyopia: A mini-review.

Authors:  Dennis M Levi; David C Knill; Daphne Bavelier
Journal:  Vision Res       Date:  2015-01-29       Impact factor: 1.886

4.  Dichoptic movie viewing treats childhood amblyopia.

Authors:  Simone L Li; Alexandre Reynaud; Robert F Hess; Yi-Zhong Wang; Reed M Jost; Sarah E Morale; Angie De La Cruz; Lori Dao; David Stager; Eileen E Birch
Journal:  J AAPOS       Date:  2015-10       Impact factor: 1.220

5.  A pilot randomized clinical trial of intermittent occlusion therapy liquid crystal glasses versus traditional patching for treatment of moderate unilateral amblyopia.

Authors:  Jingyun Wang; Daniel E Neely; Jay Galli; Joshua Schliesser; April Graves; Tina G Damarjian; Jessica Kovarik; James Bowsher; Heather A Smith; Dana Donaldson; Kathryn M Haider; Gavin J Roberts; Derek T Sprunger; David A Plager
Journal:  J AAPOS       Date:  2016-07-12       Impact factor: 1.220

6.  Psychosocial and clinical determinants of compliance with occlusion therapy for amblyopic children.

Authors:  A Searle; P Norman; R Harrad; K Vedhara
Journal:  Eye (Lond)       Date:  2002-03       Impact factor: 3.775

7.  Outcome study of stereopsis in relation to duration of misalignment in congenital esotropia.

Authors:  Malcolm R Ing; Lisa M Okino
Journal:  J AAPOS       Date:  2002-02       Impact factor: 1.220

8.  Stability of visual acuity improvement following discontinuation of amblyopia treatment in children aged 7 to 12 years.

Authors:  Richard W Hertle; Mitchell M Scheiman; Roy W Beck; Danielle L Chandler; Darron A Bacal; Eileen Birch; Raymond H Chu; Jonathan M Holmes; Deborah L Klimek; Katherine A Lee; Michael X Repka; David R Weakley
Journal:  Arch Ophthalmol       Date:  2007-05

9.  Treating amblyopia with liquid crystal glasses: a pilot study.

Authors:  Abraham Spierer; Judith Raz; Omry Benezra; Rafi Herzog; Evelyne Cohen; Ilana Karshai; David Benezra
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-02-17       Impact factor: 4.799

Review 10.  Perceptual learning as a potential treatment for amblyopia: a mini-review.

Authors:  Dennis M Levi; Roger W Li
Journal:  Vision Res       Date:  2009-02-27       Impact factor: 1.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.